The company AstraZeneca released a statement on the safety of the coronavirus vaccine. The statement says there is no evidence of an increased risk of thrombosis among vaccinated people in any age group.
“Around 17 million people in the EU and UK have now received our vaccine, and the number of cases of blood clots reported in this group is lower than the hundreds of cases that would be expected among the general population. The nature of the pandemic has led to increased attention in individual cases and we are going beyond the standard practices for safety monitoring of licensed medicines in reporting vaccine events, to ensure public safety.
“In terms of quality, there are also no confirmed issues related to any batch of our vaccine used across Europe, or the rest of the world. Additional testing has, and is, being conducted by ourselves and independently by European health authorities and none of these re-tests have shown cause for concern.
“During the production of the vaccine more than 60 quality tests are conducted by AstraZeneca, its partners and by more than 20 independent testing laboratories. All tests need to meet stringent criteria for quality control and this data is submitted to regulators within each country or region for independent review before any batch can be released to countries,” is said in the statement.
The company says public safety is paramount to them. The available evidence does not prove that the vaccine is the cause, and the company also points out that in order to beat the pandemic, it is important for people to get the vaccine.
By Ketevan Skhirtladze